Pierfranco Conté
University of Padua(IT)Istituto Oncologico Veneto(IT)IRCCS San Camillo Hospital(IT)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation(2017)3,124 cited
- → Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer(2019)2,463 cited
- → Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study(2000)2,273 cited
- → Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer(2016)1,957 cited
- → Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.(2005)1,597 cited
- → The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2